CVRx (CVRX) Stock: Buy, Sell, or Hold?
CVRX - CVRx, Inc. Common Stock
$1.53
-0.01 (-0.33%)
▼
5d:
-43.52%
30d:
-50.33%
90d:
-72.91%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When CVRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CVRX is down 43.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CVRX is down 43.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CVRX is currently trading at $1.52, which is considered oversold relative to its 30-day fair value range of $2.36 to $3.25.
Technical Outlook: Technically, CVRX is in a strong downtrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVRX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.58 (+199.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVRX is in a strong downtrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVRX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.58 (+199.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.36 -
$3.25
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding CVRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 199.6% below Wall St target ($4.58)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.36 -
$3.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$3.07
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.81
Wall Street Target
$4.58
(+199.6%)
Revenue Growth (YoY)
15.6%
Profit Margin
-84.9%
Share & Embed Analysis
Last updated: October 02, 2026 3:15 PM ET
Data refreshes hourly during market hours. Next update: 4:15 PM
Data refreshes hourly during market hours. Next update: 4:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
Advanced CVRX Option Strategies
Professional options setups generated by AI based on today's CVRX price and gamma walls.
